Literature DB >> 19833638

Clinicopathologic features in resected subcentimeter lung cancer--status of lymph node metastases.

Qianjun Zhou1, Kenji Suzuki, Yo-ichi Anami, Shiaki Oh, Kazuya Takamochi.   

Abstract

Widely used low dose helical thoracic computed tomography (CT) scan in screening results is detecting more and more small-sized lung cancers. Whether systematic lymph node (LN) dissection should be done or not on subcentimeter lung cancers still remains controversial. From June 2000 to December 2008, the records of all patients who underwent resection of primary non-small cell lung cancer (NSCLC) 1 cm or less in diameter were reviewed. LN metastases and lymphatic vessel invasion (LVI) were studied between different subgroups to determine the predictors of metastases. Of all 41 patients, there were 35 (85%) cases of adenocarcinoma, 3 (7%) cases of squamous cell carcinoma, 3 (7%) cases of other types. There were 6 (15%) cases with nodal metastases. Lymphatic invasion was found in 11 (27%) patients. Tumor differentiation, visceral pleural involvement, preoperative serum carcinoembryonic antigen (CEA), ground-glass opacity content on CT and blood vessel invasion (BVI) were significant predictors for both LN metastases and LVI. Systematic LN dissection is recommended for subcentimeter patients with good risk, however, if the patient is female, or with normal CEA, or with ground-glass opacity, or with Noguchi A or B type, surgeons might omit the procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833638     DOI: 10.1510/icvts.2009.216119

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  9 in total

1.  Does less equal more? The curious issue of small-sized lung cancer.

Authors:  Katarzyna Żanowska; Jarosław Kużdżał
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Microsized lung adenocarcinoma vs. small-sized lung adenocarcinoma: clinical characteristics, advantages and surgical implications.

Authors:  Giuseppe Mangiameli; Pierfilippo Crucitti; Gaetano Rocco
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 3.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

4.  Prognostic implication of lymphatic vessel invasion in stage IB (pT2aN0M0) non-small cell lung cancer.

Authors:  Kunio Araki; Yoshin Adachi; Hiroyuki Metsugi; Takeshi Tokushima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-09-14

5.  CT and histopathologic characteristics of lung adenocarcinoma with pure ground-glass nodules 10 mm or less in diameter.

Authors:  Fang Wu; Shu-Ping Tian; Xin Jin; Rui Jing; Yue-Qing Yang; Mei Jin; Shao-Hong Zhao
Journal:  Eur Radiol       Date:  2017-04-06       Impact factor: 5.315

6.  Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.

Authors:  Yong-Kui Zhang; Zheng-da Chai; Lin-Lin Tan; Zhao-Yu Wang; Zhi-Jun Chen; Han-Bo Le; Wang-Yu Zhu
Journal:  World J Surg Oncol       Date:  2017-03-17       Impact factor: 2.754

7.  Surgical result in non small cell lung cancer patients presenting with ground glass opacity predominant lesion less than 2 cm: Anatomic versus wedge resection.

Authors:  Ching-Feng Wu; Jui-Ying Fu; Ying-Sheng Li; Chi-Tsung Wen; Yung-Liang Wan; Yun-Hen Liu; Ming-Ju Hsieh; Ching-Yang Wu
Journal:  Biomed J       Date:  2020-11-07       Impact factor: 7.892

8.  Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.

Authors:  Jun Wang; Baocheng Wang; Weipeng Zhao; Yan Guo; Hong Chen; Huili Chu; Xiuju Liang; Jingwang Bi
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  The value of pulmonary nodule diameter and consolidation/tumor rate in the prediction of lymph node metastasis in early-stage (cT1N0M0) lung adenocarcinoma.

Authors:  Weipeng Shao; Zhaohua Zhang; Zhan Liu; Zhenrong Zhang; Hongliang Sun; Xiaowei Wang; Hongxiang Feng; Chaoyang Liang; Deruo Liu
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.